IGF1R and nasopharyngeal carcinoma: Importantly, immunostaining of bone metastases from clinical nasopharyngeal carcinoma showed that IGF-1R was abundantly expressed in tumor cells and IGF-1 in microenvironmental cells (Fig. 3e).